Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Genfit stock | $3.6

Learn how to easily invest in Genfit stock.

Genfit SA is a biotechnology business based in the US. Genfit shares (GNFT) are listed on the NASDAQ and all prices are listed in US Dollars. Genfit employs 122 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Genfit

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GNFT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Genfit stock price (NASDAQ: GNFT)

Use our graph to track the performance of GNFT stocks over time.

Genfit shares at a glance

Information last updated 2021-10-18.
Latest market close$3.60
52-week range$3.50 - $6.15
50-day moving average $3.83
200-day moving average $3.98
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.11

Buy Genfit shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Genfit stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Genfit price performance over time

Historical closes compared with the close of $3.6 from 2021-10-22

1 week (2021-10-15) -2.17%
1 month (2021-09-24) -6.25%
3 months (2021-07-23) -5.26%
6 months (2021-04-23) -15.09%
1 year (2020-10-23) -19.46%
2 years (2019-10-23) -75.17%
3 years (2018-10-20) N/A
5 years (2016-10-20) N/A

Genfit financials

Revenue TTM $5.3 million
Gross profit TTM $7.8 million
Return on assets TTM -17.88%
Return on equity TTM -122.45%
Profit margin 0%
Book value $0.71
Market capitalisation $172.2 million

TTM: trailing 12 months

Shorting Genfit shares

There are currently 8,895 Genfit shares held short by investors – that's known as Genfit's "short interest". This figure is 4.4% down from 9,307 last month.

There are a few different ways that this level of interest in shorting Genfit shares can be evaluated.

Genfit's "short interest ratio" (SIR)

Genfit's "short interest ratio" (SIR) is the quantity of Genfit shares currently shorted divided by the average quantity of Genfit shares traded daily (recently around 8552.8846153846). Genfit's SIR currently stands at 1.04. In other words for every 100,000 Genfit shares traded daily on the market, roughly 1040 shares are currently held short.

However Genfit's short interest can also be evaluated against the total number of Genfit shares, or, against the total number of tradable Genfit shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Genfit's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Genfit shares in existence, roughly 0 shares are currently held short) or 0.0002% of the tradable shares (for every 100,000 tradable Genfit shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Genfit.

Find out more about how you can short Genfit stock.

Genfit share dividends

We're not expecting Genfit to pay a dividend over the next 12 months.

Genfit share price volatility

Over the last 12 months, Genfit's shares have ranged in value from as little as $3.5 up to $6.15. A popular way to gauge a stock's volatility is its "beta".

GNFT.US volatility(beta: 1.16)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genfit's is 1.1576. This would suggest that Genfit's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Genfit overview

Genfit S. A. , a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test. Genfit S.

Frequently asked questions

What percentage of Genfit is owned by institutions?
Currently 1.392% of Genfit shares are held by institutions.
How many people work for Genfit?
Latest data suggests 122 work at Genfit.
When does the fiscal year end for Genfit?
Genfit's fiscal year ends in December.
Where is Genfit based?
Genfit's address is: Parc EurasantE, Loos, France, 59120
What is Genfit's ISIN number?
Genfit's international securities identification number is: US3722791098
What is Genfit's CUSIP number?
Genfit's Committee on Uniform Securities Identification Procedures number is: 372279109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site